Immunoreactivity for SHH, PTC, SMO, and GLI-1 was detected in both epithelial-derived odontogenic tumors and epithelial-mesenchymal-derived odontogenic tumors with or without dental hard tissue formation. This evidence concerns the gene SMO and odontogenic neoplasm.